Ryan Specialty Holdings, Inc. (NYSE:RYAN) Given Average Rating of “Hold” by Brokerages

Ryan Specialty Holdings, Inc. (NYSE:RYAN) has received a consensus recommendation of “Hold” from the twelve research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $73.50.

Several research analysts have recently commented on RYAN shares. Wells Fargo & Company boosted their price objective on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. Morgan Stanley initiated coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price on the stock. The Goldman Sachs Group increased their price objective on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. Barclays lifted their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Finally, Bank of America increased their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th.

Ryan Specialty Stock Down 0.2 %

RYAN opened at $63.89 on Tuesday. The company’s 50-day moving average price is $70.23 and its two-hundred day moving average price is $64.86. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty has a twelve month low of $41.65 and a twelve month high of $75.97. The stock has a market cap of $16.73 billion, a price-to-earnings ratio of 82.97, a PEG ratio of 1.52 and a beta of 0.67.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The company had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. During the same period last year, the firm earned $0.32 EPS. Ryan Specialty’s revenue for the quarter was up 20.5% on a year-over-year basis. As a group, equities analysts expect that Ryan Specialty will post 1.82 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.69%. Ryan Specialty’s dividend payout ratio (DPR) is currently 57.14%.

Insider Buying and Selling

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $67.39, for a total value of $2,358,650.00. Following the transaction, the director now directly owns 65,100 shares of the company’s stock, valued at approximately $4,387,089. The trade was a 34.97 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 126,936 shares of company stock valued at $8,536,282. 11.10% of the stock is owned by insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of institutional investors and hedge funds have recently made changes to their positions in RYAN. Hollencrest Capital Management purchased a new stake in Ryan Specialty during the 3rd quarter valued at $25,000. Assetmark Inc. bought a new position in Ryan Specialty during the third quarter valued at $34,000. Crewe Advisors LLC purchased a new stake in shares of Ryan Specialty in the second quarter valued at $39,000. Quarry LP lifted its holdings in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock worth $54,000 after acquiring an additional 422 shares during the last quarter. Finally, GAMMA Investing LLC boosted its stake in shares of Ryan Specialty by 106.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock worth $83,000 after purchasing an additional 644 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.